Hanall Biopharma Co.,Ltd (009420.KS)
009420.KS Stock Price Chart
Explore Hanall Biopharma Co.,Ltd interactive price chart. Choose custom timeframes to analyze 009420.KS price movements and trends.
009420.KS Company Profile
Discover essential business fundamentals and corporate details for Hanall Biopharma Co.,Ltd (009420.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 Jan 2000
Employees
309.00
Website
https://www.hanall.co.krCEO
Sean Jeong
Description
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.
009420.KS Financial Timeline
Browse a chronological timeline of Hanall Biopharma Co.,Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 20 Jan 2026
Upcoming earnings on 28 Oct 2025
Earnings released on 30 Jul 2025
EPS came in at ₩11.54 , while revenue for the quarter reached ₩40.68B , beating expectations by +9.36%.
Earnings released on 28 Apr 2025
EPS came in at -₩4.00 falling short of the estimated ₩6.89 by -158.06%, while revenue for the quarter reached ₩36.15B .
Earnings released on 23 Jan 2025
EPS came in at ₩31.91 , while revenue for the quarter reached ₩36.42B , beating expectations by +7.43%.
Earnings released on 30 Oct 2024
EPS came in at ₩4.00 falling short of the estimated ₩19.34 by -79.32%, while revenue for the quarter reached ₩36.84B , beating expectations by +0.56%.
Earnings released on 25 Jul 2024
EPS came in at -₩66.00 falling short of the estimated ₩14.57 by -552.99%, while revenue for the quarter reached ₩31.59B , missing expectations by -8.82%.
Earnings released on 30 Apr 2024
EPS came in at -₩6.00 , while revenue for the quarter reached ₩34.09B , beating expectations by +1.17%.
Earnings released on 24 Jan 2024
EPS came in at -₩56.48 falling short of the estimated ₩15.62 by -461.58%, while revenue for the quarter reached ₩31.72B , missing expectations by -3.74%.
Earnings released on 25 Oct 2023
EPS came in at ₩6.00 falling short of the estimated ₩16.02 by -62.55%, while revenue for the quarter reached ₩32.97B , missing expectations by -0.55%.
Earnings released on 26 Jul 2023
EPS came in at ₩144.14 surpassing the estimated ₩9.53 by +1.41K%, while revenue for the quarter reached ₩41.42B , beating expectations by +19.94%.
Earnings released on 28 Apr 2023
EPS came in at -₩25.00 falling short of the estimated ₩56.34 by -144.37%, while revenue for the quarter reached ₩28.80B , missing expectations by -5.25%.
Earnings released on 19 Jan 2023
EPS came in at -₩6.00 falling short of the estimated ₩71.63 by -108.38%, while revenue for the quarter reached ₩30.12B , missing expectations by -8.18%.
Earnings released on 26 Oct 2022
EPS came in at ₩14.00 , while revenue for the quarter reached ₩29.64B .
Earnings released on 2 Aug 2022
EPS came in at -₩2.00 , while revenue for the quarter reached ₩26.25B .
Earnings released on 27 Apr 2022
EPS came in at -₩2.00 , while revenue for the quarter reached ₩23.99B .
Earnings released on 21 Jan 2022
EPS came in at -₩18.00 , while revenue for the quarter reached ₩24.89B .
Earnings released on 27 Oct 2021
EPS came in at ₩40.00 , while revenue for the quarter reached ₩25.47B .
Earnings released on 29 Jul 2021
EPS came in at ₩64.00 , while revenue for the quarter reached ₩23.44B .
Earnings released on 6 May 2021
EPS came in at ₩88.00 , while revenue for the quarter reached ₩27.80B .
Earnings released on 19 Jan 2021
EPS came in at ₩122.65 , while revenue for the quarter reached ₩21.79B .
Earnings released on 16 Nov 2020
EPS came in at ₩73.00 , while revenue for the quarter reached ₩22.11B .
009420.KS Stock Performance
Access detailed 009420.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.